Subcutaneous interleukin-2 and interferon alpha in the treatment of patients with metastatic renal cell carcinoma-Less efficacy compared with intravenous interleukin-2 and interferon alpha. Results of a multicenter Phase II trial from the Groupe Fra (Q40570756)
Jump to navigation
Jump to search
scientific article published on December 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Subcutaneous interleukin-2 and interferon alpha in the treatment of patients with metastatic renal cell carcinoma-Less efficacy compared with intravenous interleukin-2 and interferon alpha. Results of a multicenter Phase II trial from the Groupe Fra |
scientific article published on December 2002 |
Statements
1 reference
Subcutaneous interleukin-2 and interferon alpha in the treatment of patients with metastatic renal cell carcinoma-Less efficacy compared with intravenous interleukin-2 and interferon alpha. Results of a multicenter Phase II trial from the Groupe Fra (English)
1 reference
Jean-Yves Douillard
1 reference
Alain Ravaud
1 reference
Rémy Delva
1 reference
Fréderic Gomez
1 reference
Christine Chevreau
1 reference
Jean Peny
1 reference
Bruno Coudert
1 reference
Sylvie Négrier
1 reference
Groupe Français d'Immunothérapie
1 reference
1 December 2002
1 reference
1 reference
95
1 reference
11
1 reference
2324-2330
1 reference
Identifiers
1 reference
1 reference